The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment
Abstract
It is unclear whether white matter hyperintensities (WMHs), magnetic resonance imaging markers of small‐vessel cerebrovascular disease, promote neurodegeneration and associated clinical decline in Alzheimer's disease (AD), or simply co‐occur with recognized pathogenic processes.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 13, 2015
- Source ID
- 10.1016/j.jalz.2015.05.014
Entities
People
- Adam M. Brickman
- Giuseppe Tosto
- Jamie L. Hamilton
- Molly E. Zimmerman
- Owen T. Carmichael
- The Alzheimer’s Disease Neuroimaging Initiative*
Organizations
- Albert Einstein College of Medicine
- Alzheimer's Disease Neuroimaging Initiative
- Columbia University
- Fordham University
- Foundation for the National Institutes of Health
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- Northern California Institute for Research and Education
- Pennington Biomedical Research Center
- United States Department of Defense